GLP-1s Are Growing In Popularity As Weight Loss Drugs But Losing Steam Among Diabetics, Study Suggests 0 23.07.2024 00:00 Forbes.com Semaglutide—the brand name for Ozempic and Wegovy—was the most prescribed GLP-1 in 2023, and accounted for over 88% of all new prescriptions. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
